Bibliography

Export 9109 results:
Filters: First Letter Of Keyword is C  [Clear All Filters]
M
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
Matlow J.N, Bronskill S.E, Gruneir A., Bell C.M, Stall N.M, Herrmann N., Seitz D.P, Gill S.S, Austin P.C, Fischer H.D et al..  2017.  Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. Journal of the American Geriatrics Society. 65(7):1535-1542.
Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.
Matlow J.N, Bronskill S.E, Gruneir A., Bell C.M, Stall N.M, Herrmann N., Seitz D.P, Gill S.S, Austin P.C, Fischer H.D et al..  2017.  Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. Journal of the American Geriatrics Society. 65(7):1535-1542.
Matlow J.N, Bronskill S.E, Gruneir A., Bell C.M, Stall N.M, Herrmann N., Seitz D.P, Gill S.S, Austin P.C, Fischer H.D et al..  2017.  Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. Journal of the American Geriatrics Society. 65(7):1535-1542.
Matlow J.N, Bronskill S.E, Gruneir A., Bell C.M, Stall N.M, Herrmann N., Seitz D.P, Gill S.S, Austin P.C, Fischer H.D et al..  2017.  Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. Journal of the American Geriatrics Society. 65(7):1535-1542.
H
Hirdes JP, Curtin-Telegdi N, Mathias K, Perlman CM, Saarela T, Kolbeinsson H, Valdimarsdóttir R, Morris JN, Fries BE, Rabinowitz T et al..  2019.  Clinical Assessment Protocols (CAPs) en Santé Mentale InterRAI Complément Aux Instruments d'évaluation de la Santé Mentale en Milieux Communautaires et Hospitaliers, Edition Française Pour la Suisse. :232.
Hirdes JP, Curtin-Telegdi N, Mathias K, Perlman CM, Saarela T, Kolbeinsson H, Valdimarsdóttir R, Morris JN, Fries BE, Rabinowitz T et al..  2018.  interRAI Mental Health Clinical Assessment Protocols (CAPs) zur Verwendung mit Mental Health Assessment-Instrumenten im ambulanten und stationären Bereich, Deutschsprachige Ausgabe für die Schweiz. :230.
Hirdes JP, Curtin-Telegdi N, Mathias K, Perlman CM, Saarela T, Kolbeinsson H, Valdimarsdóttir R, Morris JN, Fries BE, Rabinowitz T et al..  2012.  Guides d’analyse par domaine d’intervention (GAD) en santé mentale interRAI : Complément aux instruments d’évaluation de la santé mentale en milieux communautaires et hospitaliers, MH CAPs Canadian French Edition. :224.
Hirdes JP, Curtin-Telegdi N, Mathias K, Perlman CM, Saarela T, Kolbeinsson H, Valdimarsdóttir R, Morris JN, Fries BE, Rabinowitz T et al..  2011.  interRAI Mental Health Clinical Assessment Protocols (CAPs) for Use with Community and Hospital-Based Mental Health Assessment Instruments. :214.
Hirdes JP, Curtin-Telegdi N, Mathias K, Perlman CM, Saarela T, Kolbeinsson H, Valdimarsdóttir R, Morris JN, Fries BE, Rabinowitz T et al..  2011.  interRAI Mental Health Clinical Assessment Protocols (CAPs): For Use with Community and Hospital-based Mental Health Assessment Instruments, Canadian Edition. :214.